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Abstract
Background: The Mycobacterium tuberculosis Beijing genotype is biologically different from other
genotypes. We aimed to clinically and immunologically compare human tuberculosis caused by
Beijing and non-Beijing strains.
Methods: Pulmonary tuberculosis patients were prospectively enrolled and grouped by their M.
tuberculosis genotypes. The clinical features, plasma cytokine levels, and cytokine gene expression
levels in peripheral blood mononuclear cells (PBMC) were compared between the patients in
Beijing and non-Beijing groups.
Results: Patients in the Beijing group were characterized by significantly lower frequency of fever
(odds ratio, 0.12, p = 0.008) and pulmonary cavitation (odds ratio, 0.2, p = 0.049). Night sweats
were also significantly less frequent by univariate analysis, and the duration of cough prior to
diagnosis was longer in Beijing compared to non-Beijing groups (medians, 60 versus 30 days, p =
0.048). The plasma and gene expression levels of interferon (IFN) γ and interleukin (IL)-18 were
similar in the two groups. However, patients in the non-Beijing group had significantly increased IL-
4 gene expression (p = 0.018) and lower IFN-γ : IL-4 cDNA copy number ratios (p = 0.01).
Conclusion: Patients with tuberculosis caused by Beijing strains appear to be less symptomatic
than those who have disease caused by other strains. Th1 immune responses are similar in patients
infected with Beijing and non-Beijing strains, but non-Beijing strains activate more Th2 immune
responses compared with Beijing strains, as evidenced by increased IL-4 expression.
Background
The Mycobacterium tuberculosis Beijing genotype was first
described in 1995 because of its predominance in the Bei-
jing area of China, the high similarity of IS6110 RFLP pat-
terns, and the identical polymorphism pattern of the
direct repeat region of M. tuberculosis genome between iso-
lates [1]. Thereafter, it has been shown that strains of this
genotype are also predominant in other East Asian areas
[2-4] and prevalent all over the world [5,6]. The selective
advantage of the Beijing genotype has led to the postula-
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tion that it may be an 'escape variant' of mass bacillus Cal-
mette-Guérin (BCG) vaccination [1]. In addition, Beijing
strains have been reported to be associated with various
phenotypes, such as drug-resistance [2,7-10], treatment
failure and tuberculosis relapse [11], and febrile response
to treatment [12]. Studies in mice have shown that Beijing
strains are more virulent and do not favor Th1 immune
response [13,14].
These findings suggest that the Beijing genotype strains
behave differently from non-Beijing genotype strains.
However, there has been no study performed to compare
the immune responses in patients infected by Beijing and
non-Beijing strains. In this prospective study, we aimed to
determine whether there are clinical and biological differ-
ences in the host response to infections caused by Beijing
and non-Beijing strains. In particular we hypothesized
that Beijing strains elicit a weaker Th1 immune response,
as shown by a reduced production of plasma IFN-γ.
Methods
Subjects and setting
Inpatients with pulmonary tuberculosis were prospec-
tively and consecutively enrolled from Tan Tock Seng
Hospital (TTSH), and National University Hospital
(NUH) from September 2004 to May 2005. Subject inclu-
sion criteria were: (1) clinical presentation and radio-
graphic findings considered to be strongly suggestive of
pulmonary tuberculosis by the primary physicians, (2) ≥
18 years old, (3) antituberculous treatment naïve or not
longer than 48 hours, (4) able and willing to give
informed consent. Patients who had a past history of
tuberculosis, who were known to have human immuno-
deficiency virus (HIV) infection or other coexisting sys-
temic diseases, such as chronic renal failure, diabetes
mellitus, and neoplastic diseases, and pregnant or breast-
feeding women were excluded. Approval for this study
was granted by the Ethics Committee of the National
Healthcare Group (NHG), Singapore. Written informed
consent was obtained from all study subjects.
Demographic and clinical data collection
Demographic (date of birth, place of birth, sex, and race),
clinical, and routine laboratory testing data were collected
by interview of patients and/or from medical records. The
data of BCG scar, BCG vaccination history, TB contact his-
tory, and risk factors for HIV infection were collected by
interview of the subjects. The information on clinical
symptoms and their durations, including cough, fever,
night sweats, haemoptysis, weight loss, appetite loss, and
chest pain, were first collected from medical records and
confirmed through patient interviews. Routine tempera-
ture charts were examined covering the time of admission
until the time of enrolment. Axillary temperature was
recorded every 6 hours using a digital thermometer in
both hospitals. The patient was defined having fever if
there was a recorded temperature of > 37.5°C. Routine
laboratory test data including total and differential white
blood cell counts, hemoglobin, sputum smear, culture
and drug-susceptibility test results were collected. Anemia
was defined when hemoglobin < 13 g/dL in males and <
11.8 g/dL in females. All patients were screened for risk
factors of HIV infection and offered HIV serology testing.
Chest X-ray (CXR) films were reviewed at each institution
by a single clinician (TKL and AKYO) experienced in the
diagnosis and management of tuberculosis who were
blinded to M. tuberculosis genotyping results. The disease
extent on CXR was classified as: (1) unilateral disease, (2)
bilateral disease, (3) cavitary disease, (4) pleural effusion,
and (5) miliary disease.
DNA extraction and genotyping of M. tuberculosis
Sputum specimens were collected from each subject at
enrolment. Sputum samples were first decontaminated
and liquefied with 1% N-Acetyl-L-Cysteine (NALC)-2%
NaOH. DNA was extracted using phenol-chloroform/iso-
amyl alcohol, precipitated with absolute ethanol and
washed with 70% ethanol according to standard protocol.
DNA was finally dissolved in 50 μl distilled water.
Spoligotyping was performed using a commercial kit (Iso-
gen Bioscience BV, Maarssen, the Netherlands) according
to the manufacturer's protocol. Spoligotyping patterns
were translated to 15 octal codes as suggested before [15].
Mycobacterial interspersed repetitive unit-variable
number tandem repeat (MIRU-VNTR) typing was per-
formed as previously described [16,17]. Two μl of sputum
DNA sample was used in each PCR reaction for these gen-
otyping analyses. MIRU-VNTR allele number was manu-
ally converted according to amplicon size.
Isolation of plasma and PBMC
Blood samples collected in heparinized tubes were centri-
fuged at 300 × g for 10 minutes to separate plasma and
blood cells. Plasma was recovered and further centrifuged
at 14,000 rpm for 15 minutes at 4°C, and then recovered
in 0.5 ml aliquots and stored in -80°C freezer. The precip-
itated blood cells were resuspended in appropriate vol-
ume of RPMI 1640 Media and subjected to PBMC
isolation by Ficoll-Paque gradient centrifugation.
Cytokine ELISA
Blood plasma levels of IFN-γ, IL-2, IL-4, IL-13, and IL-18
were measured using quantitative ELISA kits (Bender
MedSystems, Austria) according to the manufacturer's
protocols and each sample was assayed in duplicate. The
sensitivity of these kits were 0.66 pg/ml, 2.3 pg/ml, 0.66
pg/ml, 0.99 pg/ml, 9.2 pg/ml, respectively. A high sensi-BMC Infectious Diseases 2006, 6:105 http://www.biomedcentral.com/1471-2334/6/105
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tivity (0.06 pg/ml) IFN-γ kit was used to measure some
samples with very low level of IFN-γ.
Quantification of cDNA by Real-Time PCR
Total RNA was extracted from 2 × 106 peripheral blood
mononuclear cells (PBMCs) using TRIZOL® reagent (Inv-
itrogen, California, USA) according to the manufacturer's
protocol. cDNA was reverse transcribed from total RNA
using the 1st Strand cDNA Synthesis Kit for RT-PCR
(AMV) (Roche Applied Science). The cDNA of reverse
transcribed cytokine genes IFN-γ, IL-2, IL-4, IL-13, and IL-
18, and housekeeping gene β-actin were quantified by
quantitative real-time PCR using the LightCycler™ Fast-
Start Master Sybr®Green I kit on the Roche LightCycler
apparatus (Roche Applied Science). The quantitative real-
time PCR primers and standards for these genes were
obtained from Search-LC GmbH (Heidelberg, Germany)
and the manufacturer's protocols were followed. Melting
curve analysis was performed to confirm the identity and
specificity of PCR products. All cytokine cDNA copies
were normalized to the housekeeping gene β-actin.
Statistical analysis
χ2 test or Fisher's exact test was used to analyze categorical
variables. Student's t test was used to compare normally
distributed continuous variables and those variables
which were normally distributed after log-transformation.
Multivariate logistic regression was used to adjust for
potential confounding factors. A p value of <0.05 was con-
sidered statistically significant. Odds ratios (OR) and 95%
confidence intervals (CI) were calculated.
Results
Patient enrolment and determination of M. tuberculosis 
genotypes
A total of 54 patients were enrolled in this study (35 from
TTSH and 19 from NUH). One of the 54 patients was
found to be HIV-infected, thus was excluded from further
analysis. Of the remaining patients, 16 tested negative for
HIV antibodies. Those who were not tested did not have
any apparent risk factors for HIV infection nor any evi-
dence of immune suppression noted on physical exami-
nation. Two further patients were excluded because they
were unable to provide a sputum specimen for genotyp-
ing. Nine patients were excluded because they were cul-
ture negative, sputum smear negative for acid-fast bacilli
and did not have M. tuberculosis detected by either spoli-
gotyping or MIRU-VNTR typing.
Forty-two patients had culture-proven, drug-susceptible
(to rifampicin, streptomycin, isoniazid, and ethambutol)
pulmonary tuberculosis. Of these 42, 38 (90.5%) were
smear positive. M. tuberculosis DNA was detected in the
sputum sample and successfully typed by MIRU-VNTR
typing in 41 cases, and by spoligotyping in 39 cases. All
the cases of failure of genotyping were also smear nega-
tive. The single case that could not be typed by either
method was excluded from further analysis. Therefore, the
study analysis concerns 41 culture-proven tuberculosis
patients with genotyping data.
Twenty-one (51.2%, 21/41) patients were infected with
Beijing strains (Table 1). Of these, 19 isolates had the typ-
ical Beijing spoligotype which is absent of spacers 1–34
but contains spacers 35–43 [18,19]. One isolate (N04)
showed Beijing-like spoligotype which has been demon-
strated also belonging to the Beijing lineage [19]. The
remaining one isolate (N07) was not detected by spoligo-
typing, but MIRU-VNTR typing showed that it had a typi-
cal cluster MIRU-VNTR pattern (223325173533) specific
for Beijing strains. Based on spoligotypes and/or MIRU-
VNTR patterns, the remaining 20 isolates were assigned to
non-Beijing genotypes: the Haarlem family (6 isolates,
14.6%), the Latin American and Mediterranean (LAM)
family (1 isolate, 2.4%), the T family (4 isolates, 9.8%),
and the East Africa Indian (EAI) family (9 isolates, 22%).
Demographic and epidemiological characteristics
Table 2 presents the demographic and epidemiologic
characteristics of the subjects segregated by M. tuberculosis
Beijing and non-Beijing genotypes. The distributions of
sex, ethnicity, and age did not differ significantly between
the two groups. The frequency of past BCG vaccination
and the proportion of smear positive cases were similar in
the two groups. The median score for the positive smears
was 3+ in each group. Four patients had known contact
history with family members (2 in each group). The distri-
butions of Beijing and non-Beijing isolates were similar at
the two hospitals.
Clinical and radiological features
As shown in Table 3, cough was the most common symp-
tom for the pulmonary tuberculosis patients, 38 of the 41
(92.7%) patients had cough. The less frequent manifesta-
tions were fever (26/41, 63.4%), and weight loss (28/41
68.3%). The frequencies of haemoptysis, appetite loss,
night sweats, and chest pain were even lower.
There was no significant difference in the frequency of
cough between Beijing and non-Beijing infected patients
(p = 0.125). However, in the 18 patients who had cough
and were infected with Beijing strains, the duration of
cough before the diagnosis varied widely from 14 to 1440
days (4 years) with a median of 60 days. Only 39% (7/18)
of such patients were identified and diagnosed within one
month. For the patients infected with non-Beijing strains,
the range of the duration was much narrower, from 2 to
180 days with a median of 30 days. Much higher propor-
tion (65%, 13/20) of the patients was identified within
one month. The individual cough duration is shown inBMC Infectious Diseases 2006, 6:105 http://www.biomedcentral.com/1471-2334/6/105
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Figure 1. The difference between the two groups is statisti-
cally significant (p  = 0.048), indicating that patients
infected with Beijing strains presented with longer dura-
tion of cough before the diagnosis.
Fever was recorded in 9 (42.9%) of the 21 patients
infected with Beijing strains and 17 (85.0%) of the 20
patients infected with non-Beijing strains [OR (95% CI),
0.13 (0.03–0.57), p = 0.005]. In addition to fever, night
sweats were less frequently reported in patients infected
with Beijing strains [OR (95% CI), 0.20 (0.04–0.99), p =
0.049]. To further test these associations, we performed
multivariate logistic regression analysis. Independent var-
iables included sex, age, and ethnicity, though they did
not differ significantly between the two groups, as well as
fever and night sweats. The inverse association between
febrile response and Beijing strains remained strong after
multivariate adjustment [OR (95% CI), 0.12 (0.02–0.63),
p  = 0.008]. However, the inverse association between
night sweats and Beijing strains was no longer statistically
significant after the multivariate adjustment [OR (95%
CI), 0.20 (0.02–1.75), p = 0.145].
Table 1: Genotyping result of M. tuberculosis isolates
Isolates MIRU-VNTR Spoligotypes Genotypes
N07 223325173533 ND Beijing
N08 223325173533 000000000003771 Beijing
T21 223325173533 000000000003771 Beijing
T32 223325173533 000000000003771 Beijing
T38 223325173533 000000000003771 Beijing
T41 223325173533 000000000003771 Beijing
T44 223325173533 000000000003771 Beijing
T45 223325173533 000000000003771 Beijing
T47 223325173533 000000000003771 Beijing
T49 223325173533 000000000003771 Beijing
T55 223325173533 000000000003771 Beijing
N14 223325173333 000000000003771 Beijing
T51 223325173433 000000000003771 Beijing
T18 223325193533 000000000003771 Beijing
N05 223325153513 000000000003771 Beijing
T53 223325163534 000000000003771 Beijing
N13 222325173543 000000000003771 Beijing
T11 222325173543 000000000003771 Beijing
T33 223325171531 000000000003771 Beijing
T52 233225173443 000000000003771 Beijing
N04 222325173543 000000000000771 Beijing
T34a 2223251735n3 400000001000200 Haarlem
T03 222325143323 557367770000661 Haarlem
N26 222325153323 777340770720771 Haarlem
T50 226325153323 477777774020771 Haarlem
T12 122325153423 776001370020771 Haarlem
T19 222425153324 777777777720771 Haarlem
N22 224326143327 777777606760771 LAM
T37 225125113322 777777776760600 T
T36 224226123323 777377236760771 T
N28 242325152312 777367770760621 T
T42 232325142322 767777777760771 T
T24 255326222513 577377777413771 EAI
T35 254326223432 677377477413771 EAI
T30 274326223432 677377477413771 EAI
T54 254326223432 677777477413771 EAI
N09 254225223522 477777477413771 EAI
T02 254326223434 477777777413071 EAI
T40 254326223432 000000007413771 EAI
T48 364225223533 777777000000011 EAI
N01 264326223432 ND EAI
MIRU-VNTR patterns are based on the 12 loci as described in reference [16]. Spoligotypes are presented as 15 octal codes as recommended in 
reference [15]. ND, not detected.
an = 10.BMC Infectious Diseases 2006, 6:105 http://www.biomedcentral.com/1471-2334/6/105
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The chest radiographic abnormalities associated with
infections of Beijing and non-Beijing strains were com-
pared (Table 3). There was significantly less cavitary dis-
ease in patients infected with Beijing strains [OR (95%
CI), 0.20 (0.04–0.99), p  = 0.049]. No difference was
observed in the frequency of unilateral and bilateral non-
cavitary disease, and pleural effusion. Miliary disease was
not found in the subjects.
The frequency of anemia in the entire study group was
65.9% (27/41), and there was no difference between the
two groups (Table 3). Table 3 also presents total and dif-
ferential counts of white blood cells of the patients. The
mean counts for total white blood cells, lymphocytes,
eosinophils, and basophils were not significant different
in each group. The mean monocyte count was signifi-
cantly higher in the non-Beijing group (mean, 901/μl)
compared to the Beijing group (mean, 656/μl) (p  =
0.014).
Plasma cytokine and cytokine gene expression analysis
Blood samples were collected from 40 of the 41 tubercu-
losis patients. Plasma IL-2, IL-4, and IL-13 were not
detectable by the ELISA kits, thus not shown. The plasma
levels of IFN-γ and IL-18 were similar between patients
infected with Beijing and non-Beijing strains (Figure 2)
Of the 40 blood samples collected and prepared for
cytokine gene expression analysis, the first 15 samples had
very low RNA yields, thus the cDNA transcribed from
these samples was too low to be reliably quantified. The
results presented below pertain to the 25 samples in
which satisfactory RNA samples were obtained. The 25
samples were from 12 patients infected with Beijing
strains (8 males, 66.7%; mean age, 52, SD, 14) and 13
patients infected with non-Beijing strains (5 males,
38.5%; mean age, 48, SD, 21). These characteristics were
similar between the subgroup patients and the whole
group of study subjects (refer to Table 2).
The expression of cytokine genes was standardized as per
105 β-actin cDNA copies. The expression level of IL-13 was
too low to be detected by the quantitative real-time PCR,
thus not shown. As shown in Figure 3, the cDNA copies of
IFN-γ, IL-2 and IL-18 did not differ significantly between
the Beijing and non-Beijing groups. The median cDNA
copies for IFN-γ, IL-2 and IL-18 were respectively 232
(range, 77–691), 7 (range, 0–78), and 314 (range, 120–
715) in patients infected with Beijing strains, and 228
(range, 39–491), 10 (range, 0–30), 355 (range, 81–1067)
in patients infected with non-Beijing strains. The cDNA
copies of IL-4 were significantly higher in patients infected
with non-Beijing strains (median = 26, range, 9–87) com-
pared to those with Beijing strains (median = 16, range, 0–
68) (p = 0.018).
We also compared the IFN-γ : IL-4 cDNA copy number
ratio between the Beijing and non-Beijing groups. Two
Table 2: Characteristics of patients by M. tuberculosis genotypes
Characteristics Beijing n = 21 (%) Non-Beijing n = 20 (%) p Value
Male sex 14 (66.7) 10 (50.0) 0.297
Ethnicity 0.286
Chinese 14 (66.7) 12 (60.0)
Malay 7 (33.3) 6 (30.0)
Indian 0 (0) 2 (10.0)
Age (year) 0.325
≤ 30 4 (19.0) 6 (30.0)
31–59 12 (57.1) 11 (55.0)
≥ 60 5 (23.8) 3 (15.0)
BCG 0.303
Yes 11 (52.4) 13 (65.0)
No/unknown 10 (47.6) 7 (35.0)
Sputum Smear 0.486
Positive 19 (90.5) 19 (95.0)
Median scores 3+ 3+
Known contact history 2 (9.5) 2 (10.0) 0.959
Residentships 0.141
Singapore residenta 17 (80.9) 12 (60.0)
Foreigner 4 (19.1) 8 (40.0)
Hospitals 0.796
TTSH 15 (71.4) 15 (75.0)
NUH 6 (28.6) 5 (25.0)
NOTE. Beijing, Beijing genotype; non-Beijing, non-Beijing genotypes; BCG, bacillus Calmette-Guérin.
aCitizens and permanent residents.BMC Infectious Diseases 2006, 6:105 http://www.biomedcentral.com/1471-2334/6/105
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patients who had no detectable IL-4 cDNA copies were
assumed having 1 cDNA copy in order to calculate the
ratios. Patients infected with non-Beijing strains showed
significantly lower IFN-γ : IL-4 cDNA copy number ratios
than those infected with Beijing strains (p = 0.01) (Figure
4).
Discussion
In this study we recruited consecutive patients with clini-
cally defined pulmonary tuberculosis to analyze the clini-
cal and immunological differences between M. tuberculosis
genotypes. All the subjects had microbiologically con-
firmed tuberculosis, and the manner of recruitment and
pattern of symptoms suggests that they are likely to be rep-
resentative of the population of tuberculosis patients pre-
senting to a typical general practitioner, polyclinic or
hospital emergency department in Singapore. In spite of
the reluctance of some patients to undergo HIV testing, we
were able to definitively exclude HIV co-infection in many
of the participants, and establish the absence of risk fac-
tors in the remainder. Given that the rate of HIV coinfec-
tion in tuberculosis patients is less than 1% in Singapore
(unpublished data), it is unlikely that a significant pro-
portion of the remainder would be HIV positive.
Fever is a common manifestation of pulmonary tubercu-
losis and is one of the few that can be measured objec-
tively. The frequency with which fever has been observed
in patients with tuberculosis varies widely from approxi-
mately 34% to 94% [20-23]. Patients with fever are more
often symptomatic, more likely to have advanced disease,
more likely to be smear positive, and tend to be younger
[21,22]. In this study we made the interesting and poten-
tially important observation that 85% of patients infected
with non-Beijing strains had fever, whereas only 43% of
those infected with Beijing strains had fever, and this large
difference is statistically significant.
We used a definition of fever that depended on objective
observations made while patients were hospitalized, and
Table 3: Clinical and chest X-ray manifestations of patients by M. Tuberculosis genotypes
Parameters Beijing n = 21 (%) Non-Beijing n = 20 (%) Univariate analysis
OR (95% CI) p value
Clinical presentations
Cough 18 (85.7) 20 (100) 0.00 (0.00–1.27) 0.125
Median duration 
(range)a
60 (14–1440) 30 (2–180) 0.048
Fever 9 (42.9) 17 (85.0) 0.13 (0.03–0.57) 0.005
Haemoptysis 4 (19.0) 6 (30.0) 0.55 (0.14–2.22) 0.414
Weight loss 16 (76.2) 12 (60.0) 2.13 (0.58–7.87) 0.265
Appetite loss 6 (28.6) 4 (20.0) 1.60 (0.40–6.39) 0.523
Night sweats 2 (9.5) 7 (35.0) 0.20 (0.04–0.99) 0.049
Chest pain 2 (9.5) 4 (20.0) 0.42 (0.08–2.29) 0.343
CXR presentations
Unilateral disease 7 (33.3) 8 (40.0) 0.75 (0.22–2.61) 0.658
Bilateral disease 13 (61.9) 11 (55.0) 1.33 (0.39–4.52) 0.654
Pleural effusion 1 (4.8) 1 (5.0) 0.95 (0.09–9.75) 0.972
Cavity 2 (9.5) 7 (35.0) 0.20 (0.04–0.99) 0.049
WBC count (cells/μl)
Total WBC (mean ± 
SD)
8629 ± 3331 10415 ± 3996 0.150
Lymphocytes (mean ± 
SD)
1376 ± 614 1563 ± 983 0.496
Monocytes (mean ± SD) 656 ± 340 901 ± 361 0.014
Eosinophils (mean ± SD) 144 ± 194 80 ± 82 0.193
Basophils (mean ± SD) 32 ± 17 40 ± 43 0.474
Anemiab 14 (66.7) 13 (65.0) 1.08 (0.31–3.81) 0.910
Hemoglobin (g/dL)
Male (mean ± SD) 11.8 ± 1.2 11.3 ± 1.6
Female (mean ± SD) 11.6 ± 1.9 11.3 ± 1.4
Beijing, Beijing genotype; non-Beijing, non-Beijing genotypes; OR, odds ratio; CI, confidence interval; CXR, chest X-ray; WBC, white blood cells; 
SD, standard deviation.
aUnit is in day.
bHemoglobin < 13 g/dL in males and < 11.8 g/dL in females.BMC Infectious Diseases 2006, 6:105 http://www.biomedcentral.com/1471-2334/6/105
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recorded by nursing staff who were obviously unaware of
the genotype of M. tuberculosis with which the patient is
infected. In addition to fever, we also found that night
sweats were significantly less common in patients infected
with Beijing strains. This latter finding agrees with the
IFN-γ : IL-4 cDNA copy number ratio of pulmonary tubercu- losis patients Figure 4
IFN-γ : IL-4 cDNA copy number ratio of pulmonary 
tuberculosis patients. Patients infected with non-Beijing 
strains had significantly lower ratios than those infected with 
Beijing strains (p = 0.01). The bars indicate log median ratios.
Plasma cytokine levels Figure 2
Plasma cytokine levels. Plasma levels of IFN-γ and IL-18 in 
pulmonary tuberculosis patients were quantified using ELISA 
assay. Patients infected with Beijing and non-Beijing strains 
showed similar levels of IFN-γ (p = 0.994) and IL-18 level (p = 
0.341). The bars indicate the log median levels in each group.
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findings of a large study performed in Russia by Drob-
niewski et al. [24] to examine differences between patients
infected with Beijing and non-Beijing strains. In that
study, night sweats were found significantly less often
(OR, 0.7) in patients infected with Beijing strains and the
association remained significant after multivariate adjust-
ment. However, in that study there was no significant dif-
ference in the frequency of fever between Beijing and non-
Beijing groups. The definition of fever was not given and
the overall rate (approximately 30% in both groups) sug-
gests that some under-reporting of fever may have
occurred. Although we found that the frequency of fever
and of night sweats differed between the Beijing and non-
Beijing groups, after multivariate analysis only fever
remained significant. This is not surprising as the two
symptoms often occur together in the same patient, and
so it is difficult to ascertain an independent effect. The
important point is that our study agrees with the study
from Russia that there is a difference in the clinical sys-
temic host response to Beijing and non-Beijing genotype
strains. In addition, Drobniewski et al. [24] have sug-
gested that sub-Beijing families may be different in path-
ogenicity or transmissibility. The Beijing isolates in our
study and those in the Russian study may belong to differ-
ent sub-Beijing families and this may be related with the
inconsistence between the two studies.
The presence of a constitutional symptom such as fever
will usually lead patients to seek medical attention. Con-
versely, the absence of such symptoms or a more indolent
presentation may therefore lead to delays in consultation
and make the disease less identifiable, thus increasing the
likelihood of transmission in the case of tuberculosis. To
examine this hypothesis, we compared the duration of
cough of the subjects before the diagnosis by Beijing and
non-Beijing genotypes, because cough is the most com-
mon route of spreading the bacteria. We found that
patients infected with Beijing strains had significant
longer duration of cough compared to those infected with
non-Beijing strains. This may partially account for why
the  M. tuberculosis Beijing genotype is more prevalent.
One limitation of this observation is that the data of
cough duration was based on the patients' subjective
description, and this may not be very accurate. Further-
more, other socioeconomic factors may influence
patient's decision for medical attention. Therefore, a
larger study is needed to answer questions about the con-
sequences of the differences in symptoms on presenta-
tion, diagnosis, and transmission of tuberculosis.
We found that there was a significant higher frequency of
cavitary disease in patients infected with non-Beijing
strains. However, in studies performed in Indonesia [12]
and in The Netherlands [25] in which the CXR presenta-
tions of patients infected with Beijing and non-Beijing
strains were compared, the authors did not find any sig-
nificant difference between the two groups of patients. But
in the much larger study by Drobniewski et al. [24], infec-
tion with Beijing genotype was associated more com-
monly with advanced radiological abnormalities, defined
as multiple lung zones with fibrotic change and wide-
spread cavitation, than was non-Beijing genotype, a result
that is somewhat contrary to ours.
The plasma levels of IFN-γ and IL-18 were similar and no
difference in gene expression levels of IFN-γ, IL-2 and IL-
18 was observed between the Beijing and non-Beijing
groups. This finding in general does not suggest that Bei-
jing strains elicit a weaker Th1 immune response in tuber-
culosis patients, and differs from the observation from
mouse studies that mice infected with the Beijing strains
presented with reduced Th1 immune responses [13,14].
However, we found that patients infected with non-Bei-
jing strains had significantly higher level of IL-4 gene
expression in PBMCs and significantly lower IFN-γ : IL-4
cDNA copy number ratios compared to those infected
with Beijing strains, suggesting a relatively enhanced Th2
immune response in non-Beijing patients. This finding to
some extent agrees with a recent in vitro study [26] in
which macrophages derived from bone marrow of mice
were infected with different M tuberculosis genotype
strains. They found that cells infected with Beijing strains
induced a favorable Th1 immune response, as evidenced
by the highest mRNA and protein expression of IL-1β,
TNF-α, and IL-12, and a comparable IL-18 expression
with other M. tuberculosis genotype strains. On the other
hand, there were reduced Th2 responses in cells infected
with Beijing strains as demonstrated by diminished IL-10
mRNA levels compared with other non-Beijing strains.
This cytokine pattern is favorable to control infection. In
addition, previous studies have demonstrated that
increased IL-4 production is associated with advanced
radiological disease [27], cavitary disease [2], and progres-
sion from latent infection to active disease [29]. In the
present study, we also found that elevated IL-4 expression
was related with cavitary disease. These findings suggest
that IL-4 might play a pathogenic role in tuberculosis.
The limitations of this study include the small sample size
which means that important differences between groups
may not have been detected and some clinical data that
were obtained based on patient's subjective description
were fairly crude. Further studies based on a larger
number of cases and with more detailed clinical and lab-
oratory measurements would be useful to confirm and
extend these findings.BMC Infectious Diseases 2006, 6:105 http://www.biomedcentral.com/1471-2334/6/105
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Conclusion
Our data showed that human tuberculosis caused by the
M. tuberculosis Beijing genotype strains was associated
with significantly reduced frequency of fever, night
sweats, and pulmonary cavitation, suggesting that they
induce less inflammatory response and tissue-damage.
Th1 immune responses are similar in patients infected
with Beijing and non-Beijing strains; but the increased IL-
4 expression in the patients infected with non-Beijing
strains suggests that non-Beijing strains activate relatively
more Th2-polarized immunity compared to Beijing
strains.
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